Radiation boost added to standard care in fight against tough breast cancer
NCT ID NCT07254858
Summary
This study is testing if adding a short, precise course of radiation (SBRT) to standard chemotherapy and immunotherapy before surgery works better for shrinking high-risk, hormone-positive breast cancer. About 302 patients will be randomly assigned to receive either the standard two-drug combo or that same combo plus the extra radiation. The main goal is to see if the three-part treatment helps more patients achieve a complete disappearance of cancer cells in the tumor and lymph nodes after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR+/HER2- BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.